BioSpace News Archive

Ascentage Pharma (6855.HK), and Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), jointly announce that the novel drug candidate olverembatinib of Guangzhou HealthQuest Pharma Co., Ltd., Inc., a wholly-owned subsidiary of Ascentage Pharma, has been approved by the China National Medical Products Administration (NMPA).

Everest Medicines and Providence Therapeutics (“Providence”) jointly announced today that the companies have started working on a new version of COVID-19 vaccine specifically targeting the new Omicron variant.

Aditxt, Inc., a biotech innovation company with a mission to improve the health of the immune system, announced the launch of an underwritten public offering.

ABM Therapeutics announced that its IND application for ABM-1310, a new-generation BRAF inhibitor, has been approved by the National Medical Products Administration to conduct Phase 1 clinical trials in patients of advanced solid tumors with BRAF mutation in China.

A stress test, also called an exercise stress test, usually involves physical exercise such as walking on a treadmill or riding a stationary bicycle or given a drug that mimics the effects of exercise, to show how the heart works during a physical activity.

The demand within the global self-injection device market is slated to increase in the years to come.

Peptide receptor radionuclide therapy (PRRT) is a molecular therapy which is also called radioisotope therapy. This type of therapy is used to treat a specific type of cancer called neuroendocrine tumors.

Administration of ventilator support without the use of an artificial invasive airway (i.e. tracheostomy tube or endotracheal tube) is referred as non-invasive ventilation.

The global heat pumps market is all set to witness remarkable growth avenues in the forecast period of 2019 to 2029.

The global immunoglobulins market is set to grow impressively at a CAGR of 7.0% during the forecast period. The market is poised to reach a valuation of US$ 20.7 Bn by 2026-end.